Glucose-Na-K Baxter

Glucose-Na-K Baxter is an intravenous solution formulated with magnesium chloride hexahydrate, potassium chloride, sodium chloride, glucose, and sodium acetate trihydrate. It is supplied as a sterile, ready-to-use fluid for infusion in clinical settings. The product is manufactured for the European market and is available by prescription only. It is intended for use under the supervision of qualified health-care professionals in hospitals and other acute care facilities.

Glucose-Na-K Baxter is used as an electrolyte and carbohydrate source in intravenous therapy to support patients who require fluid replacement or electrolyte balance. - Replenishment of potassium, sodium, and magnesium in patients with electrolyte depletion. - Provision of glucose for energy metabolism during peri-operative or critical-care periods. - Maintenance of acid-base balance when combined with sodium acetate. - Support of intravenous fluid therapy in patients unable to tolerate oral intake. - Dilution and administration of other intravenous medications that require a compatible electrolyte carrier.

Adverse reactions to Glucose-Na-K Baxter are generally infrequent, but they may occur with any intravenous solution. These effects are typically monitored by laboratory tests and clinical observation during and after the infusion. Common: - Mild irritation at the infusion site, such as erythema or discomfort. - Transient increase in serum potassium or magnesium levels that resolves without intervention. - Slight hyperglycemia in patients receiving large volumes. - Nausea or headache during infusion. - Local phlebitis due to solution osmolarity. Serious: - Severe hyperkalemia leading to cardiac arrhythmia. - Hypermagnesemia causing hypotension, respiratory depression, or cardiac conduction abnormalities. - Acute fluid overload with pulmonary edema.

Glucose-Na-K Baxter should be administered only after careful assessment of the patient’s clinical status and laboratory values. - Verify electrolyte concentrations (Na+, K+, Mg2+) before infusion. - Adjust infusion rate in patients with renal impairment or heart failure. - Avoid rapid administration in neonates or patients at risk of fluid overload. - Monitor blood glucose levels, especially in diabetic patients. - Use aseptic technique to prevent contamination. - Discontinue if signs of allergic reaction or infusion site inflammation appear.

Certain medications and clinical conditions may alter the safety or effectiveness of Glucose-Na-K Baxter when given intravenously. Avoid: - Concurrent infusion of potassium-sparing diuretics or ACE inhibitors in patients with hyperkalemia risk. - Co-administration with other magnesium-containing solutions that could cause excess magnesium. - Use with hypertonic glucose solutions that may increase osmolar load. Use with caution: - Loop diuretics that promote electrolyte loss; monitor levels closely. - Calcium channel blockers; watch for additive effects on cardiac conduction. - Blood products; ensure compatible electrolyte balance.